Is Iron polymaltose registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 8 valid registrations of Iron polymaltose, including FEROSE SYRUP 50MG-5ML (10 mg/ml, Syrup, SAR 14.35); FEROSE TAB (EQV.TO 100MG OF IRON) (100 mg, Tablet, SAR 19.30); Feromenta (10 mg/ml, Oral solution, SAR 10.45); Feromenta (100 mg, Chewable tablet, SAR 15.60); HEMAMAX 100 MG CHEWABLE OR SWALLOWABLE TABLETS (100 mg, Chewable tablet, SAR 17.35).

Active substance

Iron polymaltose

SFDA 10

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
FEROSE SYRUP 50MG-5ML	10 mg/ml	Syrup · Oral use	1 Bottle	SAR 14.35	NCE · OTC	SPIMACO ADDWAEIH	Valid
FEROSE TAB (EQV.TO 100MG OF IRON)	100 mg	Tablet · Oral use	30 Blister	SAR 19.30	NCE · OTC	SPIMACO ADDWAEIH	Valid
Feromenta	10 mg/ml	Oral solution · Oral use	1 Bottle	SAR 10.45	Generic · OTC	DAMMAM PHARMA	Valid
Feromenta	100 mg	Chewable tablet · Oral use	30 Blister	SAR 15.60	Generic · OTC	DAMMAM PHARMA	Valid
HEMAMAX 100 MG CHEWABLE OR SWALLOWABLE TABLETS	100 mg	Chewable tablet · Oral use	30 Blister	SAR 17.35	Generic · OTC	DEEF PHARMACEUTICAL INDUSTRIES	Valid
HEMAMAX 50 MG-5ML SYRUP	10 mg/ml	Syrup · Oral use	1 Bottle	SAR 11.60	Generic · OTC	DEEF PHARMACEUTICAL INDUSTRIES	Valid
IROKID 50MG-5ML SYRUP	10 mg/ml	Syrup · Oral use	1 Bottle	SAR 12.90	Generic · OTC	MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES	Valid
PIANKA 50 MG/ 5 ML SYRUP	10 mg/ml	Syrup · Oral use	1 Bottle	SAR 12.55	Generic · OTC	Jordan Sweden Medical and Sterilization Co.	Valid
FEROSE 50MG-ML DROPS	50 mg/ml	Oral drops · Oral use	1 Dropper Container	SAR 20.05	NCE · OTC	SPIMACO ADDWAEIH	Withdrawn by MAH · Not Marketed
PIANKA 50 MG/5 ML SYRUP	10 mg/ml	Syrup · Oral use	1 Bottle	SAR 10.45	Generic · OTC	Jordan Sweden Medical and Sterilization Co.	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

ADULT ACUTE MYELOID LEUKAEMIA (AML); ANEMIA IN CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE ASSOCIATED ANEMIA; MATERNAL AND CHILD HEALTHCARE- SUPPLEMENTATION FOR MOTHER AND CHILD

Combinations containing Iron polymaltose

Folic acid + iron polymaltose

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.